Clinical trial · Interventional
Early Support in Primary Care for People Starting Treatment for Cancer
NCT03719716CI-TRIAL-00050564GI-ACPcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a feasibility, randomised controlled trial (RCT) of a person-centred care planning intervention involving patients recently diagnosed with a poor prognosis cancer who are starting a palliative oncology treatment in a Scottish regional cancer centre.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Esophagus | Malignant Esophageal Neoplasm | ALIAS | 0.90 |
| Cancer of Pancreas | Malignant Pancreatic Neoplasm | ALIAS | 0.90 |
| Cancer of Stomach | Malignant Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Anticipatory care planning letter | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Early support group
- description
- This group receive the Anticipatory care planning letter to take to their GP and the GP receives a copy of the Scottish Anticipatory Care Planning information leaflet and a short communication guide about ACP.
- interventionNames
- Other: Anticipatory care planning letter
- type
- NO_INTERVENTION
- label
- Usual care group
- description
- No change to standard care from oncology services and primary care
Primary outcomes (1)
- measure
- Health related quality of life: EuroQol EQ-5D-5L
- timeFrame
- Baseline to 48 weeks or death
- description
- Health related quality of life assessed using the EuroQol EQ-5D-5L. The EQ-5D-5L has 2 components: There is a descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions. The EQ VAS (visual analogue scale) records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. The users guide gives details of the scoring system: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L\_UserGuide\_2015.pdf
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * People with advanced, inoperable oesophageal, gastric or pancreatic cancers * People being offered palliative chemotherapy and/or radiotherapy Exclusion Criteria: * People too ill to participate or give informed consent. * Patient who are not fit for oncology treatment or who opt for best supportive care. * People with other life-limiting conditions likely to cause death within 6 months. * People with moderate to severe cognitive impairment that precludes completions of questionnaires or participation in interviews. * People unable to give informed consent or communicate by telephone with the researcher.
References
Publications (0)
Data not yet available
No reference posted for this study.